Quarterly report pursuant to Section 13 or 15(d)

SHARE BASED PAYMENTS (Tables)

v3.22.1
SHARE BASED PAYMENTS (Tables)
3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Schedule of share-based payment expense
The following table presents share-based payment expense for the three months ended March 31, 2022 and 2021:
 
  Three months ended March 31,
  2022 2021
Restricted stock $ 1,201  $ 645 
Stock options 43  308 
Warrants 339  374 
Total $ 1,583  $ 1,327 
Schedule of company’s outstanding stock purchase warrants
Restricted stock activity for the three months ended March 31, 2022 is presented in the following table:
 
  Shares Weighted Average Grant Date Fair Value
Nonvested, December 31, 2021
483,750  $ 20.19 
Granted 595,500  $ 10.84 
Vested (247,000) $ 4.40 
Forfeited (13,750) $ 5.72 
Nonvested, March 31, 2022
818,500  $ 18.18 
Schedule of company’s outstanding stock purchase warrants
The table below summarizes all option activity under all plans during the three months ended March 31, 2022:
 
Options Shares Weight -
Average
Exercise
Price
Weighted -
Average
Remaining
Contractual
Term
Weighted -
Average
Grant Date
Fair Value
Outstanding at December 31, 2021
906,425  $ 4.38  2.85 $ 2.45 
Granted —  —  —  — 
Exercised —  —  —  — 
Forfeited or expired (187,427) 5.12  —  2.89 
Outstanding at March 31, 2022
718,998  $ 4.02  2.59 $ 4.02 
Options vested at March 31, 2022
679,000  $ 4.35  2.52 $ 2.44 
Schedule of company’s outstanding stock purchase warrants
A summary of the status of the Company’s outstanding stock purchase warrants for the three months ended March 31, 2022 is as follows:
 
  Warrants Weighted Average
Exercise Price
Outstanding at December 31, 2021
330,884  $ 22.14 
Issued —  — 
Exercised —  — 
Forfeited —  — 
Outstanding at March 31, 2022
330,884  $ 22.14